Pharmaceutical Drugs Global Market Opportunities And Strategies To 2021 Including: Musculoskeletal Disorders Drugs, Cardiovascular Drugs, Oncology Drugs, Anti-Infective Drugs, Metabolic Disorder Drugs, Central Nervous System Drugs, Genito-Urinary Drugs, Respiratory Diseases Drugs, Gastrointestinal Drugs, Hematology Drugs, Dermatology Drugs, Ophthalmology Drugs. Covering: Novartis AG, Sanofi S.A., Pfizer Inc. and Gilead Sciences Inc.

Pharmaceutical Drugs Global Market Opportunities And Strategies To 2021 Including: Musculoskeletal Disorders Drugs, Cardiovascular Drugs, Oncology Drugs, Anti-Infective Drugs, Metabolic Disorder Drugs, Central Nervous System Drugs, Genito-Urinary Drugs, Respiratory Diseases Drugs, Gastrointestinal Drugs, Hematology Drugs, Dermatology Drugs, Ophthalmology Drugs. Covering: Novartis AG, Sanofi S.A., Pfizer Inc. and Gilead Sciences Inc.


  • Products Id :- o&s005
  • |
  • Pages: 430
  • |
  • |
  • |
  Request for Sample Report
  Request A Quote

Executive Summary

The global pharmaceutical drug market was worth USD 934.8 billion in 2017 and has grown at a CAGR of 5.16% during 2013-2017. The market is expected to grow at a CAGR of 5.78% during 2017-2021 and is forecast to be worth USD 1,170.4 billion by 2021. Global GDP is expected to grow significantly to 2021, so the 5.78% annual growth of the global pharma market does not register in the percentage figures. Aging populations, income growth especially in emerging economies and the high prices of new drugs are factors leading to steadily increasing per capita drugs expenditure.

 

North America accounted for 36.5% of the global pharmaceutical drugs market in 2017 and was worth USD 341.1 billion. This market share was primarily due to the better healthcare system, access to high value drugs, healthcare awareness, high per capita expenditure on healthcare and high GDP of the region. Asia Pacific was the second largest region with a share of 21.8% in 2017 and the market was worth USD 200.8 billion. This was mainly due to the prevalence of chronic conditions and the large population based of the region. Western Europe was the third largest region accounting for USD 180.9 billion or 19.4% of the market. This market was driven by increased investment in research and development, aging population, ability to afford high value drugs and established healthcare system. South America was the fourth largest region accounting for USD 80.9 billion or 8.6% of the market. Rising disposable income, government healthcare policies and availability of affordable generic drugs are main drivers of this market. Eastern Europe was fifth largest region accounting for USD 60.9 billion or 6.5% of the market followed by Middle East with a share of 4.4%, USD 41.3 billion, and Africa with a market worth USD 28.8 billion in 2017.

 

At the country level, The USA was the largest country in the pharmaceutical drugs market in 2017, accounting for USD 234.7 billion or 25.1% market. The USA's per capita medical drugs spend has been and will be to 2021 the world's highest, followed by those of Australia and Germany. China was the second largest country accounting for USD 52.6 billion followed by Japan with a market worth USD 43 billion in 2017. Germany was the fourth largest country accounting for USD 37 billion in 2017. Russia was the smallest country accounting for USD 12.1 billion and this can be attributed to the presence of generics and less reliance on imported pharmaceutical drugs.

 

As a percentage of GDP in 2013 the USA's drugs expenditure was highest, but by 2017 it had been overtaken by both Brazil and Italy, whose market was worth USD 29.1 billion and USD 24.7 billion respectively, and the situation will continue to 2021. In terms of the number of pharmacist, the huge populations of India and China meant that these countries had the highest number of pharmacists in 2017. Three of the BRICs, India, China and Brazil, have low spend on pharma, despite very high numbers of pharmacists, implying that the drugs revenue per pharmacist in these countries is relatively low. With more generic drugs occupying the market, it was observed that 70% of drug sales in India were generics whereas in many Western countries it was much lower, for example in Italy generics made up only 11% of the market. New drug approvals in 2017 were highest in Brazil, 61, and lowest in the USA, followed by Europe. In part this pattern is explained by countries approving drugs approved in the USA in earlier years and the slow and difficult process for new drug approvals in the USA and Europe.

 

At the global level, pharmaceutical drugs are segmented based on the therapeutic area with drugs for musculoskeletal disorders as the largest segment worth USD 130.2 billion in 2017. Cardiovascular drugs were the second largest segment followed by oncology drugs with a market worth USD 129.6 billion and 125.9 billion respectively. Ophthalmology Drugs was the smallest major segment in the pharmaceutical drugs market worth about USD 27.7 billion.



Read More



Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications

+91-9015378249

1. Executive Summary

2. Pharmaceutical Drugs Market Characteristics

2.1. Global Pharmaceutical Drugs Market Size And Growth

2.2. Global Pharmaceutical Drugs Historic Market Growth

2.2.1. Drivers Of The Market

2.2.2. Restraints On The Market

2.3. Global Pharmaceutical Drugs Market Forecast Growth

2.3.1. Drivers Of The Market

2.3.2. Restraints On The Market

4. Global Pharmaceutical Drugs Market, PESTLE Analysis

4.1. Political

4.2. Economic

4.3. Social

4.4. Technological

4.5. Legal

4.6. Environmental

5. Pharmaceutical Drugs Market Customer Information

6. Pharmaceutical Drugs Market Regional And Country Analysis

6.1. Pharmaceutical Drugs Market, 2017, Split By Region

6.2. Pharmaceutical Drugs Market, 2013-2017, Historic And Forecast Growth Rate, Split By Region

6.3. Pharmaceutical Drugs Market, 2017, Split By Country

6.4. Pharmaceutical Drugs Market, 2013-2017, Historic And Forecast Growth Rate, By Country

7. Global Pharmaceutical Drugs Market Segmentation

7.1. Global Pharmaceutical Drugs Market, Split By Segments, 2017, USD Billion

7.1.1. Musculoskeletal Disorders Drugs

7.1.2. Cardiovascular Drugs

7.1.3. Oncology Drugs

7.1.4. Anti-infective Drugs

7.1.5. Metabolic Disorder Drugs

7.1.6. Central Nervous System Drugs

7.1.7. Genito-urinary Drugs

7.1.8. Respiratory Drugs

7.1.9. Gastrointestinal Drugs

7.1.10. Hematology Drugs

7.1.11. Dermatology Drugs

7.1.12. Ophthalmology Drugs

7.2. Global Pharmaceutical Drugs Market, 2013-2017, Historic And Forecast Growth Rate, Split By Segments

8. Pharmaceutical Drugs Market Segments And Subsegments

8.1. Musculoskeletal Disorders Drugs

8.1.1. Musculoskeletal Disorders Drugs Market Characteristics

8.1.2. Musculoskeletal Disorders Drugs Market Trends & Strategies

8.1.3. Global Musculoskeletal Disorders Drugs Market, By Subsegment

8.1.3.1. Drugs for Rheumatoid Arthritis

8.1.3.2. Muscle Relaxants

8.1.3.3. Others

8.1.4. Global Musculoskeletal Disorders Drugs Market, 2013-2017, Historic And Forecast Growth Rate, By Subsegment

8.1.5. Global Musculoskeletal Drugs Market Competitive Landscape

8.1.6. Global Musculoskeletal Drugs Market Key Mergers And Acquisitions

8.2. Cardiovascular Drugs

8.2.1. Cardiovascular Drugs Market Characteristics

8.2.2. Cardiovascular Drugs Market Trends & Strategies

8.2.3. Global Cardiovascular Drugs Market, Segmentation By Subsegment

8.2.3.1. Anti-hypertensive Drugs

8.2.3.2. Hypolipidemics

8.2.3.3. Anti Thrombotics

8.2.3.4. Other Drugs For Cardiovascular Diseases

8.2.4. Global Cardiovascular Drugs Market, 2013-2017, Historic And Forecast Growth Rate, By Subsegment

8.2.5. Global Cardiovascular Drugs Market Competitive Landscape

8.2.6. Global Cardiovascular Drugs Market Key Mergers And Acquisitions

8.3. Oncology Drugs

8.3.1. Oncology Drugs Market Characteristics

8.3.2. Oncology Drugs Market Trends & Strategies

8.3.3. Global Oncology Drugs Market, Segmentation By Subsegment

8.3.3.1. Blood Cancer

8.3.3.2. Breast Cancer

8.3.3.3. Cervical Cancer

8.3.3.4. Lung Cancer

8.3.3.5. Colorectal Cancer

8.3.3.6. Non-Small Cell Lung Cancer

8.3.3.7. Prostate Cancer

8.3.3.8. Kidney Cancer

8.3.3.9. Gastric Cancer

8.3.3.10. Brain Tumor

8.3.3.11. Pancreatic Cancer

8.3.3.12. Skin Cancer

8.3.3.13. Ovarian Cancer

8.3.3.14. Bladder Cancer

8.3.3.15. Thyroid Cancer

8.3.3.16. Others

8.3.4. Global Oncology Drugs Market, 2013-2017, Historic And Forecast Growth Rate, By Subsegment

8.3.5. Global Oncology Drugs Market Competitive Landscape

8.3.6. Global Oncology Drugs Market Key Mergers And Acquisitions

8.4. Anti-Infective Drugs

8.4.1. Anti-infective Drugs Market Characteristics

8.4.2. Anti-infective Drugs Market Trends & Strategies

8.4.3. Global Anti-Infective Drugs Market, Segmentation By Subsegment

8.4.3.1. Antivirals

8.4.3.2. Antibiotics

8.4.3.3. Antifungals

8.4.3.4. Antiparasitic

8.4.4. Global Anti-Infective Drugs Market, 2013-2017, Historic And Forecast Growth Rates, By Subsegment

8.4.5. Global Anti-Infective Drugs Market Competitive Landscape

8.4.6. Global Anti-Infective Drug Market Key Mergers and Acquisitions

8.5. Metabolic Disorders Drugs

8.5.1. Metabolic Disorders Drugs Market Characteristics

8.5.2. Metabolic Disorders Drugs Market Trends & Strategies

8.5.3. Global Metabolic Disorders Drugs Market, Segmentation By Subsegment

8.5.3.1. Anti-diabetics Drugs

8.5.3.2. Anti-thyroid drugs

8.5.3.3. Others (Hyperparathyroidism, Hypopituitarism, Hypoadrenalism)

8.5.4. Global Metabolic Disorders Drugs Market, 2013-2017, Historic And Forecast Growth Rate, By Subsegment

8.5.5. Global Metabolic Disorder Drugs Market Competitive Landscape

8.5.6. Global Metabolic Disorders Drugs Market Key Mergers And Acquisitions

8.6. Central Nervous System Drugs

8.6.1. Central Nervous System Drugs Market Characteristics

8.6.2. Central Nervous System Drugs Market Trends & Strategies

8.6.3. Global Central Nervous System Drugs Market, Segmentation By Subsegment

8.6.3.1. Anesthetics

8.6.3.2. Analgesics

8.6.3.3. Anti-Parkinson drugs

8.6.3.4. Anti-Epileptics

8.6.3.5. Other CNS drugs

8.6.4. Global Central Nervous System Drugs Market, 2013-2017, Historic And Forecast Growth Rate, By Subsegment

8.6.5. Global Central Nervous System Market Competitive Landscape

8.6.6. Global Central Nervous System Drugs Market Key Mergers And Acquisitions

8.7. Genito-Urinary Drugs

8.7.1. Genito-Urinary Drugs Market Characteristics

8.7.2. Genito-Urinary Drugs Market Trends & Strategies

8.7.3. Global Genito-Urinary Drugs Market, Segmentation By Subsegment

8.7.3.1. Hormonal Contraceptives

8.7.3.2. Drugs For Hormonal Replacement Therapy

8.7.3.3. Drugs For Infections And Others

8.7.3.4. Drugs for Benign prostatic hypertrophy

8.7.3.5. Drugs For Erectile Dysfunction

8.7.3.6. Drugs For Urinary Incontinence And Overactive Bladder

8.7.3.7. Drugs for Infertility

8.7.3.8. Diuretics

8.7.4. Global Genito-Urinary Drugs Market, 2013-2017, Historic And Forecast Growth Rate, By Segment

8.7.5. Global Genito-Urinary Drugs Market Competitive Landscape

8.7.6. Genito-urinary Drugs Market Key Mergers And Acquisitions

8.8. Respiratory Diseases

8.8.1. Respiratory Diseases Drugs Market Characteristics

8.8.2. Respiratory Diseases Drugs Market Trends & Strategies

8.8.3. Global Respiratory Diseases Market, Segmentation By Subsegment

8.8.3.1. Anti-Asthmatics And COPD Drugs

8.8.3.2. Cough And Cold Preparations

8.8.4. Global Respiratory Diseases Market, 2013-2017, Historic And Forecast Growth Rate, By Subsegment

8.8.5. Global Respiratory Diseases Drugs Market Competitive Landscape

8.8.6. Global Respiratory Drugs Market Key Mergers And Acquisitions

8.9. Gastrointestinal Drugs

8.9.1. Gastrointestinal Drugs Market Characteristics

8.9.2. Gastrointestinal Drugs Market Trends & Strategies

8.9.3. Global Gastrointestinal Drugs Market, Segmentation By Subsegment

8.9.3.1. Antiulcerants

8.9.3.2. Vitamins And Minerals

8.9.3.3. Antacids

8.9.3.4. Antiemetics And Antinauseants

8.9.3.5. Antiobesity

8.9.3.6. Antidiarrhoeals

8.9.4. Global Gastrointestinal Drugs Market, 2013-2017, Historic And Forecast Growth Rate, By Subsegment

8.9.5. Global Gastrointestinal Drugs Market Competitive Landscape

8.9.6. Global Gastrointestinal Drugs Market Key Mergers And Acquisitions

8.1. Hematology Drugs

8.10.1. Hematology Drugs Market Characteristics

8.10.2. Hematology Drugs Market Trends & Strategies

8.10.3. Global Hematology Drugs Market, Segmentation By Subsegment

8.10.3.1. Blood Products

8.10.3.2. Anemia And Other Blood Disorder Drugs

8.10.4. Global Hematology Drugs Market, 2013-2017, Historic And Forecast Growth Rate, By Subsegment

8.10.5. Global Hematology Drugs Market Competitive Landscape

8.10.6. Global Hematology Drugs Market Key Mergers And Acquisitions

8.11. Dermatology Drugs

8.11.1. Dermatology Drugs Market Characteristics

8.11.2. Dermatology Drugs Market Trends & Strategies

8.11.3. Global Dermatology Drugs Market Competitive Landscape

8.11.4. Dermatology Drugs Market Key Mergers And Acquisitions

8.12. Ophthalmology Drugs

8.12.1. Ophthalmology Drugs Market Characteristics

8.12.2. Ophthalmology Drugs Market Trends & Strategies

8.12.3. Global Ophthalmology Drugs Market, Segmentation By Subsegment

8.12.3.1. Antiglaucoma

8.12.3.2. Dry Eye Medication

8.12.3.3. Other Opthalmological Drugs

8.12.4. Global Ophthalmology Drugs Market, 2013-2017, Historic And Forecast Growth Rate, By Subsegment

8.12.5. Global Ophthalmology Drugs Market Competitive Landscape

8.12.6. Ophthalmology Drugs Market Key Mergers And Acquisitions

9. Pharmaceutical Drugs Market Comparison With Macro Economic Factors

9.1. Pharmaceutical Drugs Market Size And Percentage Of GDP, Global

9.2. Per Capita Average Pharmaceutical Drugs Expenditure, Global

9.3. Pharmaceutical Drugs Market Comparison With Macro Economic Factors Across Countries

9.3.1. Pharmaceutical Drugs Market Size, Percentage Of GDP, By Country

9.3.2. Per Capita Average Pharmaceutical Drugs Expenditure, By Country

10. Pharmaceutical Drugs Market Comparison With Industry Metrics

10.1. Number Of General Practitioners 2017, By Country

10.2. Average Pharmaceutical Drugs Revenue Per General Practitioner, 2017, By Country

10.3. Number Of Pharmacists, 2017, By Country

10.4. Average Pharmaceutical Drugs Revenue Per Pharmacist, 2017, By Country

10.5. Number Of Employees In Pharmaceutical Industry, 2017, By Country

10.6. Average Revenue Per Pharmaceutical Employee, 2017, By Country

10.7. Number Of Pharmaceutical Enterprises, 2017, By Country

10.8. Average Pharmaceutical Drugs Revenue Per Pharmaceutical Enterprise, 2017, By Country

10.9. Number Of Pharmacies Per 100,000 Population, 2017, By Country

10.1. Generic & Branded Sales Proportion By Country (Value), 2016, By Country

10.11. New Drug Approvals, 2017, By Country

11. Asia-Pacific Pharmaceutical Drugs Market

11.1. Asia-Pacific Pharmaceutical Drugs Market Overview

11.2. Asia Pacific Pharmaceutical Market

11.3. Asia Pacific Pharmaceutical Drugs Historic Market Growth

11.4. Asia Pacific Pharmaceutical Drugs Market Forecast Growth

11.5. Asia Pacific Pharmaceutical Drugs Market, Segmentation By Type

11.6. Asia Pacific Pharmaceutical Drugs Market, 2013 - 2021, Historic And Forecast Growth Rates, Segmentation By Type

12. Asia-Pacific Pharmaceutical Drugs Market: Country Analysis

12.1. China Pharmaceutical Drugs Market

12.1.1. China Pharmaceutical Drugs Market Overview

12.1.2. China Pharmaceutical Market

12.1.3. China Pharmaceutical Drugs Historic Market Growth

12.1.4. China Pharmaceutical Drugs Market Forecast Growth

12.1.5. China Pharmaceutical Drugs Market, Segmentation By Type

12.1.6. China Pharmaceutical Drugs Market, 2013 - 2021, Historic And Forecast Growth Rates, Segmentation By Type

12.2. India Pharmaceutical Drugs Market

12.2.1. India Pharmaceutical Drugs Market Overview

12.2.2. India Pharmaceutical Market

12.2.3. India Pharmaceutical Drugs Historic Market Growth

12.2.4. India Pharmaceutical Drugs Market Forecast Growth

12.2.5. India Pharmaceutical Drugs Market, Segmentation By Type

12.2.6. India Pharmaceutical Drugs Market, 2013 - 2021, Historic And Forecast Growth Rates, Segmentation By Type

12.3. Japan Pharmaceutical Drugs Market

12.3.1. Japan Pharmaceutical Drugs Market Overview

12.3.2. Japan Pharmaceutical Market

12.3.3. Japan Pharmaceutical Drugs Historic Market Growth

12.3.4. Japan Pharmaceutical Drugs Market Forecast Growth

12.3.5. Japan Pharmaceutical Drugs Market, Segmentation By Type

12.3.6. Japan Pharmaceutical Drugs Market, 2013 - 2021, Historic And Forecast Growth Rates, Segmentation By Type

12.3. Australia Pharmaceutical Drugs Market

12.3.1. Australia Pharmaceutical Market

12.3.2. Australia Pharmaceutical Drugs Historic Market Growth

12.3.3. Australia Pharmaceutical Drugs Market Forecast Growth

12.3.4. Australia Pharmaceutical Drugs Market, Segmentation By Type

12.3.5. Australia Pharmaceutical Drugs Market, 2013 - 2021, Historic And Forecast Growth Rates, Segmentation By Type

13. Western Europe Pharmaceutical Drugs Market

13.1. Western Europe Pharmaceutical Drugs Market Overview

13.2. Western Europe Pharmaceutical Market

13.3. Western Europe Pharmaceutical Drugs Historic Market Growth

13.4. Western Europe Pharmaceutical Drugs Market Forecast Growth

13.5. Western Europe Pharmaceutical Drugs Market, Segmentation By Type

13.6. Western Europe Pharmaceutical Drugs Market, 2013 - 2021, Historic And Forecast Growth Rates, Segmentation By Type

14. Western Europe Pharmaceutical Drugs Market: Country Analysis

14.1. UK Pharmaceutical Drugs Market

14.1.1. UK Pharmaceutical Drugs Market Overview

14.1.2. UK Pharmaceutical Market

14.1.3. UK Pharmaceutical Drugs Historic Market Growth

14.1.4. UK Pharmaceutical Drugs Market Forecast Growth

14.1.5. UK Pharmaceutical Drugs Market, Segmentation By Type

14.1.6. UK Pharmaceutical Drugs Market, 2013 - 2021, Historic And Forecast Growth Rates, Segmentation By Type

14.2. Germany Pharmaceutical Drugs Market

14.2.1. Germany Pharmaceutical Market

14.2.2. Germany Pharmaceutical Drugs Historic Market Growth

14.2.3. Germany Pharmaceutical Drugs Market Forecast Growth

14.2.4. Germany Pharmaceutical Drugs Market, Segmentation By Type

14.2.5. Germany Pharmaceutical Drugs Market, 2013 - 2021, Historic And Forecast Growth Rates, Segmentation By Type

14.3. France Pharmaceutical Drugs Market

14.3.1. France Pharmaceutical Market

14.3.2. France Pharmaceutical Drugs Market Historic Growth

14.3.3. France Pharmaceutical Drugs Market Forecast Growth

14.3.4. France Pharmaceutical Drugs Market, Segmentation By Type

14.3.5. France Pharmaceutical Drugs Market, 2013 - 2021, Historic And Forecast Growth Rates, Segmentation By Type

14.4. Italy Pharmaceutical Drugs Market

14.4.1. Italy Pharmaceutical Market

14.4.2. Italy Pharmaceutical Drugs Historic Market Growth

14.4.3. Italy Pharmaceutical Drugs Market Forecast Growth

14.4.4. Italy Pharmaceutical Drugs Market, Segmentation By Type

14.4.5. Italy Pharmaceutical Drugs Market, 2013 - 2021, Historic And Forecast Growth Rates, Segmentation By Type

14.5. Spain Pharmaceutical Drugs Market

14.5.1. Spain Pharmaceutical Market

14.5.2. Spain Pharmaceutical Drugs Historic Market Growth

14.5.3. Spain Pharmaceutical Drugs Market Forecast Growth

14.5.4. Spain Pharmaceutical Drugs Market, Segmentation By Type

14.5.5. Spain Pharmaceutical Drugs Market, 2013 - 2021, Historic And Forecast Growth Rates, Segmentation By Type

15. Eastern Europe Pharmaceutical Drugs Market

15.1. Eastern Europe Pharmaceutical Drugs Market Overview

15.2. Eastern Europe Pharmaceutical Market

15.3. Eastern Europe Pharmaceutical Drugs Historic Market Growth

15.4. Eastern Europe Pharmaceutical Drugs Market Forecast Growth

15.5. Eastern Europe Pharmaceutical Drugs Market, Segmentation By Type

15.6. Eastern Europe Pharmaceutical Drugs Market, 2013 - 2021, Historic And Forecast Growth Rate, Segmentation By Type

15.7. Eastern Europe Pharmaceutical Drugs Market: Country Analysis

15.7.1. Russia Pharmaceutical Drugs Market

15.7.2. Russia Pharmaceutical Drugs Historic Market Growth

15.7.3. Russia Pharmaceutical Drugs Market Forecast Growth

15.7.4. Russia Pharmaceutical Drugs Market, Segmentation By Type

15.7.5. Russia Pharmaceutical Drugs Market, 2013 - 2021, Historic And Forecast Growth Rates, Segmentation By Type

16. North America Pharmaceutical Drugs Market

16.1. North America Pharmaceutical Drugs Market Overview

16.2. North America Pharmaceutical Market

16.3. North America Pharmaceutical Drugs Historic Market Growth

16.4. North America Pharmaceutical Drugs Market Forecast Growth

16.5. North America Pharmaceutical Drugs Market, Segmentation By Type

16.6. North America Pharmaceutical Drugs Market, 2013 - 2021, Historic And Forecast Growth Rates, Segmentation By Type

16.7. North America Pharmaceutical Drugs Market: Country Analysis

16.7.1. USA Pharmaceutical Drugs Market Overview

16.7.2. USA Pharmaceutical Market

16.7.3. USA Pharmaceutical Drugs Historic Market Growth

16.7.4. USA Pharmaceutical Drugs Market Forecast Growth

16.7.5. USA Pharmaceutical Drugs Market, Segmentation By Type

16.7.6. USA Pharmaceutical Drugs Market, 2013 - 2021, Historic And Forecast Growth Rates, Segmentation By Type

17. South America Pharmaceutical Drugs Market

17.1. South America Pharmaceutical Drugs Market Overview

17.2. South America Pharmaceutical Market

17.3. South America Pharmaceutical Drugs Historic Market Growth

17.4. South America Pharmaceutical Drugs Market Forecast Growth

17.5. South America Pharmaceutical Drugs Market, Segmentation By Type

17.6. South America Pharmaceutical Drugs Market, 2013 - 2021, Historic And Forecast Growth Rates, Segmentation By Type

17.7. South America Pharmaceutical Drugs Market: Country Analysis

17.7.1. Brazil Pharmaceutical Drugs Market

17.7.2. Brazil Pharmaceutical Market

17.7.3. Brazil Pharmaceutical Drugs Historic Market Growth

17.7.4. Brazil Pharmaceutical Drugs Market Forecast Growth

17.7.5. Brazil Pharmaceutical Drugs Market, Segmentation By Type

17.7.6. Brazil Pharmaceutical Drugs Market, 2013 - 2021, Historic And Forecast Growth Rates, Segmentation By Type

18. Middle East Pharmaceutical Drugs Market

18.1. Middle East Pharmaceutical Drugs Market Overview

18.2. Middle East Pharmaceutical Market

18.3. Middle East Pharmaceutical Drugs Historic Market Growth

18.4. Middle East Pharmaceutical Drugs Market Forecast Growth

18.5. Middle East Pharmaceutical Drugs Market, Segmentation By Type

18.6. Middle East Pharmaceutical Drugs Market, 2013 - 2021, Historic And Forecast Growth Rates, Segmentation By Type

19. Africa Pharmaceutical Drugs Market

19.1. Africa Pharmaceutical Drugs Market Overview

19.2. Africa Pharmaceutical Market

19.3. Africa Pharmaceutical Drugs Historic Market Growth

19.4. Africa Pharmaceutical Drugs Market Forecast Growth

19.5. Africa Pharmaceutical Drugs Market, Segmentation By Type

19.6. Africa Pharmaceutical Drugs Market, 2013 - 2021, Historic And Forecast Growth Rates, Segmentation By Type

20. Global Pharmaceutical Drugs Market Competitive Landscape

20.1. Novartis AG

20.1.1. Company Overview

20.1.2. Products And Services

20.1.3. Strategy

20.1.4. Novartis AG Financial Performance

20.2. Sanofi

20.2.1. Company Overview

20.2.2. Products And Services

20.2.3. Strategy

20.2.4. Sanofi S.A Financial Performance

20.3. Pfizer Inc.

20.3.1. Company Overview

20.3.2. Products And Services

20.3.3. Strategy

20.3.4. Pfizer Inc. Financial Performance

20.4. Gilead Sciences Inc.

20.4.1. Company Overview

20.4.2. Products And Services

20.4.3. Strategy

20.4.4. Gilead Sciences Inc. Financial Performance

21. Key Mergers And Acquisitions In The Pharmaceutical Drugs Market

22. Pharmaceutical Drugs Market Trends And Strategies

23. Market Background: Healthcare Market

23.1. Healthcare Market Characteristics

23.2. Global Healthcare Historic Market Growth

23.2.1. Drivers Of The Market

23.2.2. Restraints On The Market

23.3. Global Healthcare Forecast Market Growth

23.3.1. Drivers Of The Market

23.3.2. Restraints On The Market

23.4. Healthcare Market Geography Regional And Country Analysis

23.4.1. Healthcare Market, 2017, By Region

23.4.2. Healthcare Market, 2013 - 2021, Historic And Forecast Growth Rates, By Region

23.4.3. Healthcare Market, 2017, By Country

23.4.4. Healthcare Market, 2013 - 2021, Historic And Forecast Growth Rates, By Country

23.5. Healthcare Market Segmentation, By Region, 2017

23.6. Healthcare Market Segmentation, By Country, 2017

23.7. Global Healthcare Market Comparison With Macro Economic Factors

23.7.1. Global Healthcare Market Size, Percentage Of GDP

23.7.2. Global Per Capita Average Healthcare Expenditure

23.7.3. Healthcare Market Comparison With Macro Economic Factors Across Countries

23.7.3.1. Healthcare Market Size, Percentage Of GDP, By Country

23.7.3.2. Per Capita Average Healthcare Expenditure, By Country

23.8. Key Mergers And Acquisitions In The Healthcare Market

23.9. Healthcare Market Trends And Strategies

30. Appendix

Figure 1: Global Pharmaceutical Drugs Market, Historic Market Size, 2013-2017 , USD Billion 31

Figure 2: Global Pharmaceutical Drugs Market, Forecast Market Size, 2017-2021 , USD Billion 35

Figure 3: Global Pharmaceutical Drugs Market, PESTLE Analysis 38

Figure 4: Pharmaceutical Drugs Market, 2017, Split By Region 43

Figure 5: Pharmaceutical Drugs Market, 2013-2017, Historic And Forecast Growth Rate, Split By Region 45

Figure 6: Pharmaceutical Drugs Market, 2017, Split By Country 46

Figure 7: Pharmaceutical Drugs Market, 2013-2017, Historic And Forecast Growth Rate, Split By Country 49

Figure 8: Global Pharmaceutical Drugs Market, Split By Segments, 2017, USD Billion 51

Figure 9: Global Pharmaceutical Drugs Market, 2013-2017, Historic And Forecast Growth Rate, Split By Segment 55

Figure 10: Global Musculoskeletal Disorders Drugs Market, Segmentation By Subsegment 61

Figure 11: Global Musculoskeletal Disorders Drugs Market, 2013-2017, Historic And Forecast Growth Rate, Split By Subsegment 62

Figure 12: Global Musculoskeletal Drugs Market, Key Competitor Market Shares, 2017, Percentage (%) 64

Figure 13: Global Cardiovascular Drugs Market, Segmentation By Subsegment 72

Figure 14: Global Cardiovascular Drugs Market, 2013-2017, Historic And Forecast Growth Rate, By Subsegment 73

Figure 15: Global Cardiovascular Drugs Market, Key Competitor Market Shares, 2017, Percentage (%) 75

Figure 16: Global Oncology Drugs Market, Segmentation By Subsegment 82

Figure 17: Global Oncology Drugs Market, 2013-2017, Historic And Forecast Growth Rate, By Subsegment 85

Figure 18: Global Oncology Drugs Market, Key Competitor Market Shares, 2017, Percentage (%) 87

Figure 19: Global Anti-Infective Drugs Market, Segmentation By Subsegment 95

Figure 20: Global Anti-Infective Drugs Market, 2013-2017, Historic And Forecast Growth Rate, By Subsegment 97

Figure 21: Global Anti-Infective Drugs Market, Key Competitor Market Shares, 2017, Percentages (%) 99

Figure 22: Global Metabolic Disorders Drugs Market, Segmentation By Subsegment 107

Figure 23: Global Metabolic Disorders Drugs Market, 2013-2017, Historic And Forecast Growth Rate, By Subsegment 108

Figure 24: Global Metabolic Disorder Drugs Market, Key Competitor Market Shares, 2017, Percentage (%) 110

Figure 25: Global Central Nervous System Drugs Market, Segmentation By Subsegment 117

Figure 26: Global Central Nervous System Drugs Market, 2013-2017, Historic And Forecast Growth Rate, By Subsegment 119

Figure 27: Global Central Nervous System Market, Key Competitor Market Shares, 2017, Percentage (%) 121

Figure 28: Global Genito-Urinary Drugs Market, Segmentation By Subsegment 129

Figure 29: Global Genito-Urinary Drugs Market, 2013-2017, Historic And Forecast Growth Rate, By Segment 131

Figure 30: Global Genito-Urinary Drugs Market, Key Competitor Market Shares, 2017, Percentage (%) 133

Figure 31: Global Respiratory Diseases Market, Segmentation By Subsegment 142

Figure 32: Global Respiratory Diseases Market, 2013-2017, Historic And Forecast Growth Rate, By Subsegment 143

Figure 33: Global Respiratory Diseases Drugs Market, Key Competitor Market Shares, 2017, Percentage (%) 144

Figure 34: Global Gastrointestinal Drugs Market, Segmentation By Subsegment 151

Figure 35: Global Gastrointestinal Drugs Market, 2013-2017, Historic And Forecast Growth Rate, By Subsegment 153

Figure 36: Global Gastrointestinal Drugs Market, Key Competitor Market Shares, 2017, Percentage (%) 155

Figure 37: Global Hematology Drugs Market, Segmentation By Subsegment 163

Figure 38: Global Hematology Drugs Market, 2013-2017, Historic And Forecast Growth Rate, By Subsegment 164

Figure 39: Global Hematology Drugs Market, Key Competitor Market Shares, 2017, Percentage (%) 165

Figure 40: Global Dermatology Drugs Market, Key Competitor Market Shares, 2017, Percentage (%) 173

Figure 41: Global Ophthalmology Drugs Market, Segmentation By Subsegment 181

Figure 42: Global Ophthalmology Drugs Market, 2013-2017, Historic And Forecast Growth Rate, By Subsegment 183

Figure 43: Global Ophthalmology Drugs Market, Key Competitor Market Shares, 2017, Percentage (%) 184

Figure 44: Pharmaceutical Drugs Market Size And Percentage Of GDP, Global 189

Figure 45: Per Capita Average Pharmaceutical Drugs Expenditure, Global 190

Figure 46: Pharmaceutical Drugs Market Size, Percentage Of GDP, By Country 191

Figure 47: Per Capita Average Pharmaceutical Drugs Expenditure, By Country 192

Figure 48: Number Of General Practitioners 2017, By Country, Thousands 194

Figure 49: Average Revenue Per General Practitioner, 2017, By Country, USD Thousands 196

Figure 50: Number Of Pharmacies Per 100,000 Population, 2017, By Country 197

Figure 51: Number Of Pharmacists, 2017, By Country, Thousands 198

Figure 52: Average Revenue Per Pharmacist, 2017, By Country, USD Thousands 199

Figure 53: Number Of Employees In Pharmaceutical Industry, 2017, By Country, Thousands 200

Figure 54: Average Revenue Per Pharmaceutical Employee, 2017, By Country, USD Thousands 202

Figure 55: Number Of Pharmaceutical Enterprises, 2017, By Country 203

Figure 56: Average Revenue Per Pharmaceutical Enterprises, 2017, By Country, USD Million 204

Figure 57: Generic & Branded Sales Proportion By Country (Value), 2017 207

Figure 58: New Drug Approvals, 2017, By Country 208

Figure 59: Asia Pacific Pharmaceutical Drugs Market, Historic Market Size, 2013-2017 , USD Billion 214

Figure 60: Asia Pacific Pharmaceutical Drugs Market, Forecast Market Size, 2017-2021 , USD Billion 216

Figure 61: Asia Pacific Pharmaceutical Drugs Market, Segmentation By Type, 2017 217

Figure 62: Asia Pacific Pharmaceutical Drugs Market, 2013-2021, Historic And Forecast Growth Rates, Segmentation By Type 218

Figure 63: China Pharmaceutical Drugs Market, Historic Market Size, 2013-2017 , USD Billion 224

Figure 64: China Pharmaceutical Drugs Market, Forecast Market Size, 2017-2021 , USD Billion 226

Figure 65: China Pharmaceutical Drugs Market, Segmentation By Type, 2017 227

Figure 66: China Pharmaceutical Drugs Market, 2013-2021, Historic And Forecast Growth Rates, Segmentation By Type 228

Figure 67: India Pharmaceutical Drugs Market, Historic Market Size, 2013-2017 , USD Billion 234

Figure 68: India Pharmaceutical Drugs Market, Forecast Market Size, 2017-2021 , USD Billion 236

Figure 69: India Pharmaceutical Drugs Market, Segmentation By Type, 2017 237

Figure 70: India Pharmaceutical Drugs Market, 2013-2021, Historic And Forecast Growth Rates, Segmentation By Type 238

Figure 71: Japan Pharmaceutical Drugs Market, Historic Market Size, 2013-2017 , USD Billion 244

Figure 72: Japan Pharmaceutical Drugs Market, Forecast Market Size, 2017-2021 , USD Billion 246

Figure 73: Japan Pharmaceutical Drugs Market, Segmentation By Type, 2017 247

Figure 74: Japan Pharmaceutical Drugs Market, 2013-2021, Historic And Forecast Growth Rates, Segmentation By Type 248

Figure 75: Australia Pharmaceutical Drugs Market, Historic Market Size, 2013-2017 , USD Billion 250

Figure 76: Australia Pharmaceutical Drugs Market, Forecast Market Size, 2017-2021 , USD Billion 252

Figure 77: Australia Pharmaceutical Drugs Market, Segmentation By Type, 2017 253

Figure 78: Australia Pharmaceutical Drugs Market, 2013-2021, Historic And Forecast Growth Rates, Segmentation By Type 254

Figure 79: Western Europe Pharmaceutical Drugs Market, Historic Market Size, 2013-2017 , USD Billion 260

Figure 80: Western Europe Pharmaceutical Drugs Market, Forecast Market Size, 2017-2021 , USD Billion 261

Figure 81: Western Europe Pharmaceutical Drugs Market, Segmentation By Type 262

Figure 82: Western Europe Pharmaceutical Drugs Market, 2013-2021, Historic And Forecast Growth rates, Segmentation By Type 264

Figure 83: UK Pharmaceutical Drugs Market, Historic Market Size, 2013-2017 , USD Billion 268

Figure 84: UK Pharmaceutical Drugs Market, Forecast Market Size, 2017-2021 , USD Billion 270

Figure 85: UK Pharmaceutical Drugs Market, Segmentation By Type, 2017 271

Figure 86: UK Pharmaceutical Drugs Market, 2013-2021, Historic And Forecast Growth Rates, Segmentation By Type 273

Figure 87: Germany Pharmaceutical Drugs Market, Historic Market Size, 2013-2017 , USD Billion 275

Figure 88: Germany Pharmaceutical Drugs Market, Forecast Market Size, 2017-2021 , USD Billion 277

Figure 89: Germany Pharmaceutical Drugs Market, Segmentation By Type, 2017 278

Figure 90: Germany Pharmaceutical Drugs Market, 2013-2021, Historic And Forecast Growth Rates, Segmentation By Type 280

Figure 91: France Pharmaceutical Drugs Market, Historic Market Size, 2013-2017 , USD Billion 282

Figure 92: France Pharmaceutical Drugs Market, Forecast Market Size, 2017-2021 , USD Billion 284

Figure 93: France Pharmaceutical Drugs Market, Segmentation By Type, 2017 285

Figure 94: France Pharmaceutical Drugs Market, 2013-2021, Historic And Forecast Growth Rates, Segmentation By Type 287

Figure 95: Italy Pharmaceutical Drugs Market, Historic Market Size, 2013-2017 , USD Billion 289

Figure 96: Italy Pharmaceutical Drugs Market, Forecast Market Size, 2017-2021 , USD Billion 291

Figure 97: Italy Pharmaceutical Drugs Market, Segmentation By Type, 2017 292

Figure 98: Italy Pharmaceutical Drugs Market, 2013-2021, Historic And Forecast Growth Rates, Segmentation By Type 293

Figure 99: Spain Pharmaceutical Drugs Market, Historic Market Size, 2013-2017 , USD Billion 296

Figure 100: Spain Pharmaceutical Drugs Market, Forecast Market Size, 2017-2021 , USD Billion 297

Figure 101: Spain Pharmaceutical Drugs Market, Segmentation By Type, 2017 298

Figure 102: Spain Pharmaceutical Drugs Market, 2013-2021, Historic And Forecast Growth Rates, Segmentation By Type 299

Figure 103: Eastern Europe Pharmaceutical Drugs Market, Historic Market Size, 2013-2017 , USD Billion 303

Figure 104: Eastern Europe Pharmaceutical Drugs Market, Forecast Market Size, 2017-2021 , USD Billion 305

Figure 105: Eastern Europe Pharmaceutical Drugs Market, Segmentation By Type, 2017 306

Figure 106: Eastern Europe Pharmaceutical Drugs Market, 2013-2021, Historic And Forecast Growth Rate, Segmentation By Type 307

Figure 107: Russia Pharmaceutical Drugs Market, Historic Market Size, 2013-2017 , USD Billion 310

Figure 108: Russia Pharmaceutical Drugs Market, Forecast Market Size, 2017-2021 , USD Billion 311

Figure 109: Russia Pharmaceutical Drugs Market, Segmentation By Type, 2017 312

Figure 110: Russia Pharmaceutical Drugs Market, 2013-2021, Historic And Forecast Growth Rates, Segmentation By Type 314

Figure 111: North America Pharmaceutical Drugs Market, Historic Market Size, 2013-2017 , USD Billion 319

Figure 112: North America Pharmaceutical Drugs Market, Forecast Market Size, 2017-2021 , USD Billion 321

Figure 113: North America Pharmaceutical Drugs Market, Segmentation By Type, 2017 322

Figure 114: North America Pharmaceutical Drugs Market, 2013-2021, Historic And Forecast Growth Rates, Segmentation By Type 324

Figure 115: USA Pharmaceutical Drugs Market, Historic Market Size, 2013-2017 , USD Billion 329

Figure 116: USA Pharmaceutical Drugs Market, Forecast Market Size, 2017-2021 , USD Billion 330

Figure 117: USA Pharmaceutical Drugs Market, Segmentation By Type, 2017 331

Figure 118: USA Pharmaceutical Drugs Market, 2013-2021, Historic And Forecast Growth Rates, Segmentation By Type 333

Figure 119: South America Pharmaceutical Drugs Market, Historic Market Size, 2013-2017 , USD Billion 338

Figure 120: South America Pharmaceutical Drugs Market, Forecast Market Size, 2017-2021 , USD Billion 340

Figure 121: South America Pharmaceutical Drugs Market, Segmentation By Type, 2017 341

Figure 122: South America Pharmaceutical Drugs Market, 2013-2021, Historic And Forecast Growth Rates, Segmentation By Type 343

Figure 123: Brazil Pharmaceutical Drugs Market, Historic Market Size, 2013-2017 , USD Billion 345

Figure 124: Brazil Pharmaceutical Drugs Market, Forecast Market Size, 2017-2021 , USD Billion 346

Figure 125: Brazil Pharmaceutical Drugs Market, Segmentation By Type, 2017 347

Figure 126: Brazil Pharmaceutical Drugs Market, 2013-2021, Historic And Forecast Growth Rates, Segmentation By Type 348

Figure 127: Middle East Pharmaceutical Drugs Market, Historic Market Size, 2013-2017 , USD Billion 352

Figure 128: Middle East Pharmaceutical Drugs Market, Forecast Market Size, 2017-2021 , USD Billion 354

Figure 129: Middle East Pharmaceutical Drugs Market, Segmentation By Type, 2017 355

Figure 130: Middle East Pharmaceutical Drugs Market, 2013-2021, Historic And Forecast Growth Rates, Segmentation By Type 357

Figure 131: Africa Pharmaceutical Drugs Market, Historic Market Size, 2013-2017 , USD Billion 361

Figure 132: Africa Pharmaceutical Drugs Market, Forecast Market Size, 2017-2021 , USD Billion 363

Figure 133: Africa Pharmaceutical Drugs Market, Segmentation By Type, 2017 364

Figure 134: Africa Pharmaceutical Drugs Market, 2013-2021, Historic And Forecast Growth Rates, Segmentation By Type 366

Figure 135: Global Pharmaceutical Drugs Market, Key Competitor Market Shares, 2017, Percentage (%) 368

Figure 136: Novartis AG Financial Performance 371

Figure 137: Sanofi Financial Performance 373

Figure 138: Pfizer Inc. Financial Performance 375

Figure 139: Gilead Sciences Inc. Financial Performance 377

Figure 140: Global Healthcare Market, Historic Market Size, 2013-2017 , USD Billion 384

Figure 141: Global Healthcare Market, Forecast Market Size, 2013-2017 , USD Billion 387

Figure 142: Healthcare Market, 2017, By Region 390

Figure 143: Healthcare Market, 2013-2021, Historic And Forecast Growth Rates, By Region 392

Figure 144: Healthcare Market, 2017, By Country 394

Figure 145: Healthcare Market, 2013-2021, Historic And Forecast Growth Rates, By Country 396

Figure 146: Healthcare Market Segmentation, By Region, 2017 398

Figure 147: Healthcare Market Segmentation, By Country, 2017 399

Figure 148: Global Healthcare Market Size, Percentage Of GDP 401

Figure 149: Global Per Capita Average Healthcare Expenditure 402

Figure 150: Global Healthcare Market Size, Percentage Of GDP, By Country 403

Figure 151: Per Capita Average Healthcare Expenditure, By Country 404

Table 1: Global Pharmaceutical Drugs Market, Historic Market Size, 2013-2017 , USD Billion 31

Table 2: Global Pharmaceutical Drugs Market, Forecast Market Size, 2017-2021 , USD Billion 35

Table 3: Pharmaceutical Drugs Market, 2017, Split By Region 43

Table 4: Pharmaceutical Drugs Market, 2013-2017, Historic And Forecast Growth Rate, Split By Region 45

Table 5: Pharmaceutical Drugs Market, 2017, Split By Country 47

Table 6: Pharmaceutical Drugs Market, 2013-2017, Historic And Forecast Growth Rate, Split By Country 49

Table 7: Global Pharmaceutical Drugs Market, Split By Segments, 2017, USD Billion 52

Table 8: Global Pharmaceutical Drugs Market, 2013-2017, Historic And Forecast Growth Rate, Split By Segment 55

Table 9: Global Musculoskeletal Disorders Drugs Market, 2017, By Subsegment 61

Table 10: Global Pharmaceutical Drugs Market, 2013-2017, Historic And Forecast Growth Rate, Split By Subsegment 62

Table 11: Global Musculoskeletal Drugs Market, Key Competitor Market Shares And Revenues, 2017, 64

Table 12: Global Cardiovascular Drugs Market, 2017, Segmentation By Subsegment 72

Table 13: Global Cardiovascular Drugs Market, 2013-2017, Historic And Forecast Growth Rate, By Subsegment 73

Table 14: Global Cardiovascular Market, Competitor Market Shares and Revenues, 2017 75

Table 15: Global Oncology Drugs Market, 2017, Segmentation By Subegment 82

Table 16: Global Oncology Drugs Market, 2013-2017, Historic And Forecast Growth Rate, By Subsegment 85

Table 17: Global Oncology Drugs Market, Competitor Market Shares and Revenues, 2017 87

Table 18: Global Anti-Infective Drugs Market, 2017, Segmentation, By Subsegment 95

Table 19: Global Anti-Infective Drugs Market, 2013-2017, Historic And Forecast Growth Rate, By Subsegment 97

Table 20: Global Anti-Infective Drugs Market, Competitor Market Shares and Revenues, 2017 99

Table 21: Global Metabolic Disorders Drugs Market, 2017, Segmentation By Segment 107

Table 22: Global Metabolic Disorders Drugs Market, 2013-2017, Historic And Forecast Growth Rate, By Subsegment 108

Table 23: Global Metabolic Disorder Drugs Market, Competitor Market Shares and Revenues, 2017 110

Table 24: Global Central Nervous System Drugs Market, 2017, Segmentation By Segment 117

Table 25: Global Central Nervous System Drugs Market, 2013-2017, Historic And Forecast Growth Rate, By Subsegment 119

Table 26: Global Central Nervous System Drugs Market, Competitor Market Shares and Revenues, 2017 121

Table 27: Global Genito-Urinary Drugs Market, 2017, Segmentation By Subsegment 129

Table 28: Global Genito-Urinary Drugs Market, 2013-2017, Historic And Forecast Growth Rate, By Subsegment 131

Table 29: Global Genito-Urinary Drugs Market, Competitor Market Shares And Reveneues, 2017 133

Table 30: Global Respiratory Diseases Market, 2017, Segmentation By Subsegment 142

Table 31: Global Respiratory Diseases Market, 2013-2017, Historic And Forecast Growth Rate, By Segment 143

Table 32: Global Respiratory Diseases Drugs Market, Competitor Market Shares And Revenues, 2017 144

Table 33: Global Gastrointestinal Drugs Market, 2017, Segmentation By Subsegment 151

Table 34: Global Gastrointestinal Drugs Market, 2013-2017, Historic And Forecast Growth Rate, By Segment 153

Table 35: Global Gastrointestinal Drugs Market, Competitor Market Shares And Revenues, 2017 155

Table 36: Global Hematology Drugs Market, 2017, Segmentation By Subsegment 163

Table 37: Global Hematology Drugs Market, 2013-2017, Historic And Forecast Growth Rate, By Subsegment 164

Table 38: Global Hematology Drugs Market, Competitor Market Shares And Revenues, 2017 165

Table 39: Global Dermatology Drugs Market, Competitor Market Shares And Revenues, 2017 173

Table 40: Global Ophthalmology Drugs Market, 2017, Segmentation, By Subsegment 181

Table 41: Global Ophthalmology Drugs Market, 2013-2017, Historic And Forecast Growth Rate, By Subsegment 183

Table 42: Global Ophthalmology Drugs Market, Competitor Market Shares And Revenues, 2017 184

Table 43: Pharmaceutical Drugs Market Size And Percentage Of GDP, Global 189

Table 44: Per Capita Average Pharmaceutical Drugs Expenditure, Global 190

Table 45: Pharmaceutical Drugs Market Size, Percentage Of GDP, By Country, 2017 191

Table 46: Per Capita Average Pharmaceutical Drugs Expenditure, By Country, 2017 192

Table 47: Number Of General Practitioners 2017, By Country, Thousands 194

Table 48: Average Revenue Per General Practitioner, 2017, By Country, USD Thousands 196

Table 49: l Number Of Pharmacies Per 100,000 Population, 2017, By Country 197

Table 50: Number Of Pharmacists, 2017, By Country, Thousands 198

Table 51: Average Revenue Per Pharmacist, 2017, By Country, USD Thousands 199

Table 52: Number Of Employees In Pharmaceutical Industry (in Thousands), 2017, By Country 200

Table 53: Average Revenue Per Pharmaceutical Employee, 2017, By Country, USD Thousands 202

Table 54: Number Of Pharmaceutical Enterprises, 2017, By Country 203

Table 55: Average Revenue Per Pharmaceutical Enterprises, 2017, By Country, USD Million 204

Table 56: Generic & Branded Sales Proportion By Country (Value), 2017 207

Table 57: New Drug Approvals, 2017, By Country 208

Table 58: Asia Pacific Pharmaceutical Drugs Market, Historic Market Size, 2013-2017 , USD Billion 215

Table 59: Asia Pacific Pharmaceutical Drugs Market, Forecast Market Size, 2017-2021 , USD Billion 216

Table 60: Asia Pacific Pharmaceutical Drugs Market, Segmentation By Type, 2017 217

Table 61: Asia Pacific Pharmaceutical Drugs Market, 2013-2021, Historic And Forecast Growth Rates, Segmentation By Type 219

Table 62: China Pharmaceutical Drugs Market, Historic Market Size, 2013-2017 , USD Billion 224

Table 63: China Pharmaceutical Drugs Market, Forecast Market Size, 2017-2021 , USD Billion 226

Table 64: China Pharmaceutical Drugs Market, Segmentation, By Type, 2017 227

Table 65: China Pharmaceutical Drugs Market, 2013-2021, Historic And Forecast Growth Rates, Segmentation By Type 229

Table 66: India Pharmaceutical Drugs Market, Historic Market Size, 2013-2017 , USD Billion 234

Table 67: India Pharmaceutical Drugs Market, Forecast Market Size, 2017-2021 , USD Billion 236

Table 68: India Pharmaceutical Drugs Market, Segmentation By Type, 2017 237

Table 69: India Pharmaceutical Drugs Market, 2013-2021, Historic And Forecast Growth Rates, Segmentation By Type 239

Table 70: Japan Pharmaceutical Drugs Market, Historic Market Size, 2013-2017 , USD Billion 244

Table 71: Japan Pharmaceutical Drugs Market, Forecast Market Size, 2017-2021 , USD Billion 246

Table 72: Japan Pharmaceutical Drugs Market, Segmentation By Type, 2017 247

Table 73: Japan Pharmaceutical Drugs Market, 2013-2021, Historic And Forecast Growth rates, Segmentation By Type 249

Table 74: Australia Pharmaceutical Drugs Market, Historic Market Size, 2013-2017 , USD Billion 250

Table 75: Australia Pharmaceutical Drugs Market, Forecast Market Size, 2017-2021 , USD Billion 252

Table 76: Australia Pharmaceutical Drugs Market, Segmentation By Type, 2017 253

Table 77: Australia Pharmaceutical Drugs Market, 2013-2021, Historic And Forecast Growth Rates, Segmentation By Type 255

Table 78: Western Europe Pharmaceutical Drugs Market, Historic Market Size, 2013-2017 , USD Billion 260

Table 79: Western Europe Pharmaceutical Drugs Market, Forecast Market Size, 2017-2021 , USD Billion 261

Table 80: Western Europe Pharmaceutical Drugs Market, Segmentation By Type 262

Table 81: Western Europe Pharmaceutical Drugs Market, 2013-2021, Historic And Forecast Growth Rates, Segmentation By Type 264

Table 82: UK Pharmaceutical Drugs Market, Historic Market Size, 2013-2017 , USD Billion 268

Table 83: UK Pharmaceutical Drugs Market, Forecast Market Size, 2017-2021 , USD Billion 270

Table 84: UK Pharmaceutical Drugs Market, Segmentation By Type, 2017 271

Table 85: UK Pharmaceutical Drugs Market, 2013-2021, Historic And Forecast Growth Rates, Segmentation By Type 273

Table 86: Germany Pharmaceutical Drugs Market, Historic Market Size, 2013-2017 , USD Billion 276

Table 87: Germany Pharmaceutical Drugs Market, Forecast Market Size, 2017-2021 , USD Billion 277

Table 88: Germany Pharmaceutical Drugs Market, Segmentation By Type, 2017 278

Table 89: Germany Pharmaceutical Drugs Market, 2013-2021, Historic And Forecast Growth Rates, Segmentation By Type 280

Table 90: France Pharmaceutical Drugs Market, Historic Market Size, 2013-2017 , USD Billion 282

Table 91: France Pharmaceutical Drugs Market, Forecast Market Size, 2017-2021 , USD Billion 284

Table 92: France Pharmaceutical Drugs Market, Segmentation By Type, 2017 285

Table 93: France Pharmaceutical Drugs Market, 2013-2021, Historic And Forecast Growth Rates, Segmentation By Type 287

Table 94: Italy Pharmaceutical Drugs Market, Historic Market Size, 2013-2017 , USD Billion 290

Table 95: Italy Pharmaceutical Drugs Market, Forecast Market Size, 2017-2021 , USD Billion 291

Table 96: Italy Pharmaceutical Drugs Market, Segmentation By Type, 2017 292

Table 97: Italy Pharmaceutical Drugs Market, 2013-2021, Historic And Forecast Growth Rates, Segmentation By Type 294

Table 98: Spain Pharmaceutical Drugs Market, Historic Market Size, 2013-2017 , USD Billion 296

Table 99: Spain Pharmaceutical Drugs Market, Forecast Market Size, 2017-2021 , USD Billion 297

Table 100: Spain Pharmaceutical Drugs Market, Segmentation By Type, 2017 298

Table 101: Spain Pharmaceutical Drugs Market, 2013-2021, Historic And Forecast Growth Rates, Segmentation By Type 300

Table 102: Eastern Europe Pharmaceutical Drugs Market, Historic Market Size, 2013-2017 , USD Billion 303

Table 103: Eastern Europe Pharmaceutical Drugs Market, Forecast Market Size, 2017-2021 , USD Billion 305

Table 104: Eastern Europe Pharmaceutical Drugs Market, Segmentation By Type, 2017 306

Table 105: Eastern Europe Pharmaceutical Drugs Market, 2013-2021, Historic And Forecast Growth Rate, Segmentation By Type 308

Table 106: Russia Pharmaceutical Drugs Market, Historic Market Size, 2013-2017 , USD Billion 310

Table 107: Russia Pharmaceutical Drugs Market, Forecast Market Size, 2017-2021 , USD Billion 311

Table 108: Russia Pharmaceutical Drugs Market, Segmentation By Type, 2017 312

Table 109: Russia Pharmaceutical Drugs Market, 2013-2021, Historic And Forecast Growth Rates, Segmentation By Type 314

Table 110: North America Pharmaceutical Drugs Market, Historic Market Size, 2013-2017 , USD Billion 319

Table 111: North America Pharmaceutical Drugs Market, Forecast Market Size, 2017-2021 , USD Billion 321

Table 112: North America Pharmaceutical Drugs Market, Segmentation By Type, 2017 322

Table 113: North America Pharmaceutical Drugs Market, 2013-2021, Historic And Forecast Growth Rates, Segmentation By Type 324

Table 114: USA Pharmaceutical Drugs Market, Historic Market Size, 2013-2017 , USD Billion 329

Table 115: USA Pharmaceutical Drugs Market, Forecast Market Size, 2017-2021 , USD Billion 330

Table 116: USA Pharmaceutical Drugs Market, Segmentation By Type, 2017 331

Table 117: USA Pharmaceutical Drugs Market, 2013-2021, Historic And Forecast Growth Rates, Segmentation By Type 333

Table 118: South America Pharmaceutical Drugs Market, Historic Market Size, 2013-2017 , USD Billion 339

Table 119: South America Pharmaceutical Drugs Market, Forecast Market Size, 2017-2021 , USD Billion 340

Table 120: South America Pharmaceutical Drugs Market, Segmentation By Type, 2017 341

Table 121: South America Pharmaceutical Drugs Market, 2013-2021, Historic And Forecast Growth Rates, Segmentation By Type 343

Table 122: Brazil Pharmaceutical Drugs Market, Historic Market Size, 2013-2017 , USD Billion 345

Table 123: Brazil Pharmaceutical Drugs Market, Forecast Market Size, 2017-2021 , USD Billion 346

Table 124: Brazil Pharmaceutical Drugs Market, Segmentation By Type, 2017 347

Table 125: Brazil Pharmaceutical Drugs Market, 2013-2021, Historic And Forecast Growth Rates, Segmentation By Type 349

Table 126: Middle East Pharmaceutical Drugs Market, Historic Market Size, 2013-2017 , USD Billion 352

Table 127: Middle East Pharmaceutical Drugs Market, Forecast Market Size, 2017-2021 , USD Billion 354

Table 128: Middle East Pharmaceutical Drugs Market, Segmentation By Type, 2017 355

Table 129: Middle East Pharmaceutical Drugs Market, 2013-2021, Historic And Forecast Growth Rates, Segmentation By Type 357

Table 130: Africa Pharmaceutical Drugs Market, Historic Market Size, 2013-2017 , USD Billion 361

Table 131: Africa Pharmaceutical Drugs Market, Forecast Market Size, 2017-2021 , USD Billion 363

Table 132: Africa Pharmaceutical Drugs Market, Segmentation By Type, 2017 364

Table 133: Africa Pharmaceutical Drugs Market, 2013-2021, Historic And Forecast Growth Rates, Segmentation By Type 366

Table 134: Global Pharmaceutical Drugs Market, Competitor Market Shares And Revenues, 2017 368

Table 135: Novartis AG Financial Performance 371

Table 136: Sanofi S.A Financial Performance 373

Table 137: Pfizer Financial Performance 375

Table 138: Gilead Sciences Financial Performance 377

Table 139: Global Healthcare Market, Historic Market Size, 2013-2017 , USD Billion 384

Table 140: Global Healthcare Market, Forecast Market Size, 2013-2017 , USD Billion 387

Table 141: Healthcare Market, 2017, Split By Region 391

Table 142: Healthcare Market, 2013-2017, Historic And Forecast Growth Rate, Split By Region 392

Table 143: Healthcare Market, 2017, Split By Country 394

Table 144: Healthcare Market, 2013-2017, Historic And Forecast Growth Rate, Split By Country 396

Table 145: Healthcare Market Segmentation, By Region, 2017 398

Table 146: Healthcare Market Segmentation, By Country, 2017 399

Table 147: Healthcare Market Size, Percentage Of GDP, Global 401

Table 148: Global Per Capita Average Healthcare Expenditure 402

Table 149: Healthcare Market Size, Percentage Of GDP, By Country 403

Table 150: Per Capita Average Healthcare Expenditure, By Country 404

Table 151: Global Pharmaceutical Drugs Market, Market Data Sources 409

To know more information on Purchase by Section, please send a mail to sales [@] kenresearch.com
 

North America: Pfizer Inc., Amgen, AbbVie, Abbott Laboratories, F. Hoffmann-La Roche, Gilead Science, Johnson & Johnson, Merck & Co., Eli Lilly and Company, Astellas Pharma, Q Pharm, 3M Pharmaceuticals

Asia-Pacific: Shanghai Pharmaceuticals, Shanghai Fosun Pharmaceutical, Cipla, Dr. Reddy's Laboratories Ltd., Sun Pharma, Takeda Pharmaceutical Company Ltd., Otsuka Pharmaceutical Co. Ltd., Daiichi Sankyo

Western Europe: Bayer, Roche, Novartis, Sanofi, GlaxoSmithKline, Teva Pharmaceutical Industries, AstraZeneca, Boehringer Ingelheim, Novo Nordisk

South America: EMS Pharma, Hypermarcas, Medley, Sanofi, Novartis, Ache, Eurofarma, Takeda, Bayer, Teuto Brasileiro, Biolab Farmaceutica, Cristalia, Libbs, Uniao Quimica, Roche, Merck, Pfizer, AstraZeneca, Boehringer Ingelheim, GlaxoSmithKline

Eatern Europe: Pharmstandard, STADA CIS Russian Holding, Sotex, Microgen, AKRIKHIN, Sanofi, Aventis, Novartis, Roche, Bayer, Pfizer, GlaxoSmithKline

Middle East: Saudi Pharmaceutical Industries and Medical Appliances Corporation (SPIMACO), Gulf Pharmaceutical Industries (Julphar), Pfizer, Merck, GSK, Abbott Laboratories

Africa: Sanofi, Novartis, Cipla, Pfizer, Roche, Bayer, Adcock Ingram, Johnson & Johnson, Aspen

Musculoskeletal Disorders Drugs, Cardiovascular Drugs, Oncology Drugs, Anti-Infective Drugs, Metabolic Disorder Drugs, Central Nervous System Drugs, Genito-Urinary Drugs, Respiratory Diseases Drugs, Gastrointestinal Drugs, Hematology Drugs, Dermatology Drugs, Ophthalmology Drugs

select a license
Single User License
USD 6000 INR 412740
Hard Copy License
USD 6000 INR 412740
CD-Rom
USD 6000 INR 412740
Site License
USD 9000 INR 619110
Corporate User License
USD 12000 INR 825480

NEWSLETTER BY CATEGORY




Testimonials

The report was very informative and gives me an interesting view on the Indian market....

We would like to thank the entire team of Ken Research in showcasing professionalism in research and quick turnaround time. We have had multiple research reports from Ken Research. The deadline communicated for research was duly met. The research reports were covering many aspects in detail. This showcases their endeavor and care for client satisfaction and a strong understanding of the clients’ requirements. Thank you again for your help...

I appreciate their diligence and determination in customizing the research project. The data proves to be valuable and accurate. I would, in future, definitely use their services again...

I would like to thank Ken research team for meeting our report deliverables. The report is very good and we appreciate your well cooperation. ...

The research you conducted was very helpful for us and the integrity of your research approach gave us great confidence in the data. Look forward to collaborating again in future...



Ken Research Private Limited, Unit 14, Tower B3, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India

download

Company Brochure

Engage with Us

sales [@] kenresearch.com